The clinical trial of a vaccine being developed in Australia for the prevention of corona virus has been discontinued. This step was taken after the participants in the trial were shown to be HIV-infected in the investigation after being vaccinated while they were not actually infected.
The Kovid-19 vaccine being developed by the University of Queensland and biotech company CSL has been discontinued. CSL told the Australian stock market in a statement and said it would stop the clinical trial.
The Australian government has tied up with four vaccine manufacturers to purchase 5.1 million doses of vaccines. This company was also one of them. CSL said in a statement that no serious adverse effects were observed in the 216 participants who took the test and that the vaccine had better measures to protect health.
However, the test results showed that the vaccine-bound antibodies caused erroneous HIV infection results in the participants. CSL said that if the vaccine had been used at the national level, it would have had a serious impact on Australia’s public health due to the flawed consequences of HIV infection among the community. This vaccine was being tested since July.
Australia’s Prime Minister Scott Morrison said that withholding the test shows that the Australian government and researchers are acting with great caution. He said that what happened today did not surprise the government. We want to be stable without any haste.